Steven Cohen Point72 Asset Management
Steven Cohen is the founder of Point72 Asset Management and previously built SAC Capital into one of the industry’s most profitable trading firms. Point72 operates a multi-manager platform combining fundamental long/short equity with systematic and other strategies. Cohen is also a major figure in sports ownership and philanthropy, while remaining one of the most closely followed names in hedge fund trading culture.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$431M |
| 2 |
NVIDIA
NVDA
|
+$220M |
| 3 |
Micron Technology
MU
|
+$182M |
| 4 |
Union Pacific
UNP
|
+$168M |
| 5 |
Southern Company
SO
|
+$162M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$459M |
| 2 |
Meta Platforms (Facebook)
META
|
+$403M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$380M |
| 4 |
Salesforce
CRM
|
+$271M |
| 5 |
Intel
INTC
|
+$271M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.27% |
| 2 | Technology | 16.9% |
| 3 | Consumer Discretionary | 11.34% |
| 4 | Industrials | 9.63% |
| 5 | Energy | 5.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
PUT
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
| $58.9K | ﹤0.01% |
+1,800
| New | +$60.6K |
|
1552
Resideo Technologies
REZI
$2.91B
| $58.3K | ﹤0.01% |
+3,303
| New | +$57K |
|
1553
Healthcare Services Group
HCSG
$1.55B
| $56.5K | ﹤0.01% |
3,784
-11,768
| -76% | -$170K |
|
1554
Ezcorp Inc
EZPW
$2.12B
| $55.3K | ﹤0.01% |
+6,594
| New | +$57.2K |
|
1555
PUT
Shell
SHEL
$255B
| $54.3K | ﹤0.01% |
900
| – | – |
|
1556
Zscaler
ZS
$27.9B
| $54.3K | ﹤0.01% |
+371
| New | +$45.3K |
|
1557
Insperity
NSP
$1.99B
| $54K | ﹤0.01% |
+454
| New | +$53.9K |
|
1558
PPG Industries
PPG
$25.1B
| $54K | ﹤0.01% |
+364
| New | +$50.8K |
|
1559
FirstCash
FCFS
$10.1B
| $53.7K | ﹤0.01% |
+575
| New | +$56.2K |
|
|
TRTN
1560
DELISTED
Triton International Limited
TRTN
| $53.6K | ﹤0.01% |
644
-1,319
| -67% | -$107K |
|
1561
Zoetis
ZTS
$31.6B
| $53.5K | ﹤0.01% |
311
-27,710
| -99% | -$4.79M |
|
1562
Cintas
CTAS
$82.4B
| $53.2K | ﹤0.01% |
428
-40,372
| -99% | -$4.74M |
|
1563
RenaissanceRe
RNR
$13.6B
| $52.6K | ﹤0.01% |
282
-16,814
| -98% | -$3.35M |
|
|
SRDX
1564
DELISTED
Surmodics
SRDX
| $52.5K | ﹤0.01% |
1,678
-8,977
| -84% | -$205K |
|
|
ALLG
1565
DELISTED
Allego N.V.
ALLG
| $52.5K | ﹤0.01% |
+19,091
| New | +$43.3K |
|
1566
AAR Corp
AIR
$5.53B
| $52K | ﹤0.01% |
+900
| New | +$48.5K |
|
1567
Ashland
ASH
$3.34B
| $50.5K | ﹤0.01% |
+581
| New | +$53.7K |
|
1568
SSR Mining
SSRM
$7.73B
| $50.1K | ﹤0.01% |
3,530
+2,500
| +243% | +$37.8K |
|
1569
CALL
Keurig Dr Pepper
KDP
$43.9B
| $50K | ﹤0.01% |
1,600
-16,100
| -91% | -$528K |
|
1570
Weibo
WB
$1.73B
| $49.9K | ﹤0.01% |
+3,804
| New | +$60.4K |
|
1571
Truist Financial
TFC
$61.6B
| $49.4K | ﹤0.01% |
1,629
-286,485
| -99% | -$8.9M |
|
1572
Edgewell Personal Care
EPC
$1.3B
| $49.3K | ﹤0.01% |
+1,193
| New | +$51K |
|
1573
CenterPoint Energy
CNP
$25.8B
| $49K | ﹤0.01% |
1,682
-1,188,843
| -100% | -$35.1M |
|
1574
Fate Therapeutics
FATE
$300M
| $48.2K | ﹤0.01% |
+10,136
| New | +$55.9K |
|
|
JOYY
1575
JOYY Inc
JOYY
$3.75B
| $48.2K | ﹤0.01% |
1,568
-256,706
| -99% | -$7.52M |
|
Similar funds
Steven Cohen's Q2 2023 Portfolio in Review
As of Q2 2023, Steven Cohen held 2,962 positions worth $33.6B, up 4.1% from $32.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Steven Cohen withdrew a net $1.43B in Q2 2023, closing 858 positions and reducing 601 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $157M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Steven Cohen opened a new position in Micron Technology worth $178M.
- Steven Cohen's largest Q2 2023 buy was Micron Technology: 2,825,000 shares worth $178M.
- Steven Cohen added most to Microsoft in Q2 2023, an estimated $431M increase.
- Steven Cohen's biggest Q2 2023 reduction was Broadcom, cutting an estimated $459M.
- Steven Cohen fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $157M.
- Steven Cohen's ten largest holdings make up 14% of its $33.6B portfolio in Q2 2023.
- Steven Cohen opened 772 new positions and closed 858 in Q2 2023.
- Steven Cohen's portfolio value rose 4.1% quarter-over-quarter to $33.6B.
Based on Point72 Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.